E1	Eq-Comparison:T1 Temporal-Period:T12 Value:T13 Unit:T19
E2	Procedure:T2 Name:T14 Duration:E1
E3	Drug:T3 Name:T15
E4	Or:T4 Arg:E3 Arg2:E5
E5	Drug:T5 Name:T16
E6	Or:T6 Arg:E5 Arg2:E7
E7	Drug:T7 Name:T17
E8	Or:T8 Arg:E7 Arg2:E9
E9	Drug:T9 Name:T18
E10	Age:T10 Eq-Comparison:E11
E11	Eq-Comparison:T11 Operator:T20 Value:T21 Temporal-Unit:T22
E12	Negation:T24 Negates:T23
T1	Eq-Comparison 44 41	planned 6 cycles
T2	Procedure 60 57	chemotherapy
T3	Drug 77 74	carboplatin
T4	Or 79 75	/
T5	Drug 90 85	paclitaxel
T6	Or 93 88	or
T7	Drug 105 100	carboplatin
T8	Or 107 101	/
T9	Drug 139 132	pegylated liposomal doxorubicin
T10	Age 148 141	Age
T11	Eq-Comparison 160 151	>18 years
T12	Eq-Temporal-Period 34 32	planned
T13	Eq-Value 37 34	6
T14	Procedure-Name 60 57	chemotherapy
T15	Drug-Name 77 74	carboplatin
T16	Drug-Name 90 85	paclitaxel
T17	Drug-Name 105 100	carboplatin
T18	Drug-Name 139 132	pegylated liposomal doxorubicin
T20	Eq-Operator 150 143	>
T21	Eq-Value 154 145	18
T22	Eq-Temporal-Unit 160 151	years
T23	Language 222 211	German
T19	Eq-Unit 44 41	cycles
T24	Negation 198 187	inadequate
A1	Eq-Temporal-Period-Value T12 future
A2	Eq-Operator-Value T20 GT
A3	Eq-Temporal-Unit-Value T22 year
R1	Using Arg1:E2 Arg2:E3
R2	Using Arg1:E2 Arg2:E5
R3	Using Arg1:E7 Arg2:E2
R4	Using Arg1:E9 Arg2:E2